Fact Sheet
PRA’s Laboratory Solutions For Drug Development
At PRA Health Sciences, we recognize that the world of clinical development is complex and dynamic, and we’ve designed our laboratories for drug…
All Results
Fact Sheet
Resource
qPCR at PRA’s Laboratories for Drug Development
We see new drug types being studied more and more, such as cell and gene therapies. For some of these drug types, qPCR is a valuable technology to…
Resource
QC Laboratory as part of CMC Services at PRA’s Laboratories for Drug Development
The quality control laboratory facilitates the acceleration of drug development, supporting Clinical Phase I and II studies. From method…
Resource
Pharmacokinetics with Ligand Binding Assays at PRA’s Laboratories for Drug Development
The PRA Bioanalytical Laboratory has over 15 years of experience in pharmacokinetic analysis of biological therapeutics in support of pre-clinical…
Resource
Chromatography & Mass Spectrometry at PRA’s Laboratories for Drug Development
With over 35 years of experience in chromatography and over 25 years in mass spectrometry, our analytical laboratories are here to help you support…
Resource
PRA Health Sciences Laboratory Publication List
A list of 2019-2020 publications from the labs team.
Resource
Anti-drug antibody assays at PRA’s Laboratory for Drug Development
The PRA Bioanalytical Laboratory has over 10 years of experience with transfer, development, validation, and bioanalysis of anti-drug antibody (ADA)…
Resource
Flow Cytometry at PRA’s Laboratories for Drug Development
PRA has 10+ years of experience performing flow cytometry in clinical trials, and we implemented a broad range of assay types to analyze sample types…
Resource
Biomarkers at PRA’s Laboratories for Drug Development
PRA understands that biomarker assays are not PK assays and that their Context of Use (CoU) must be defined prior to setting up a method. Since most…
Fact Sheet
Biotech Solutions Fact Sheet
Biotech is in our DNA. PRA has recognized the importance of emerging biopharma since our humble beginnings, when we first started partnering with…